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TtlE proteolytic activity of trypsin releases the dye
Remazol Brilliant Blue from its high molecular weight
substrate, the skin powder (Hide Powder Azure, Sigma),
with an increase in absorbance at 595 nm. Active z2-
macroglobulin (80 pg/ml) totally inhibits the proteolytic
activity of trypsin (14 pg/ml) by trapping this protease.
But after a 20 min incubation ofz2-macroglobulin at 37C
with 2 x 106 human polymorphonuclear leukocytes acti-
vated by N-formyl-L-methionyl-L-leucyl-L-phenylalanine
(10- M) and cytochalasin B (10- M), 100% of trypsin
activity was recovered, indicating a total inactivation of
0t2-macroglobuHn. Incubation with granulocyte myelo-
peroxidase also inactivates x2-macroglobulin. Hypo-
chlorous acid, a by-product of myeloperoxidase activity,
at a concentration of 10-TM also inactivates 2"
macroglobulin, which indicates that an important
cause of x2-macroglobulin inactivation by activated
polymorphonuclear leukocytes could be the activity of
myeloperoxidase.
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Introduction
During activation, the polymorphonuclear leu-
kocytes (PMNL) release numerous potent substances,
such as active oxygen species, mediators of inflam-
mation and enzymes. I," One of these enzymes,
myeloperoxidase (MPO), is included in the primary
granules of the polymorphonuclear neutrophils and
produces hypochlorous acid from hydrogen perox-
ide and chloride anion. This oxidant molecule is able
to generate chloramines and to destroy bacterial
structures resistant to proteinases. 3,4 These potent
substances, released by the activated PMNL, normally
benefit the host by destroying foreign organisms, and
the role of the proteinases would be to allow PMNL
to traverse connective tissue barriers by local destruc-
tion strictly controlled by antiproteinases.
Matheson et al. have discovered that 0tl-proteinase
inhibitor ((Xl-PI) one of the main plasmatic
antiproteinases particularly active against elastase,
can be inactivated by MPO in the presence of hydro-
gen peroxide and chloride anion and that this inac-
tivation results from oxidation into sulphoxide of the
two methionyl residues of the reactive site of zl-PI.
So, during excessive activation, the neutrophils will
release proteinases and MPO together in high con-
centrations; the oxidative inactivation of zl-PI by
MPO-generated factors will result in increasing
proteolytic destruction of tissues by proteinases,
particularly by free elastase.
( 1994 Rapid Communications of Oxford Ltd
0t2-Macroglobulin (z2-M) is another important plas-
ma antiproteinase presenting a broad reactivity with
serine-, cysteine-, aspartic- and metalloproteinases.
Its structure and antiproteinase activity have been
studied extensively in the past few years. It possesses
four identical subunits linked in pairs by disulphide
bonds forming two half molecules which are associ-
ated by non-covalent bonds. {x2-M contains a bait
area of about 35 different amino acids, each being
specifically attacked by a particular proteinase.
11
By proteolysis of a specific peptide bond of the bait
region and cleavage of a thioester bond, the binding
of a proteinase leads to a change of (x2-M conforma-
tion, so that the complex proteinase-zi-M will be
recognized quickly by macrophage receptors and
rapidly eliminated by the reticulo-endothelial sys-
tem. 12 This conformational change of 02-m leads to
the trapping of the enzyme, which then remains
active only against low molecular weight substrates,
since by steric inhibition the access to the trapped
proteinase is prohibited for high molecular weight
substrates.8,13 It has been demonstrated that 0t2-M is
vulnerable to ammonium salts, which cause the tran-
sition of (x2-M from the S-form to the F-form that differ
in electrophoretic mobility (’slow’ for S, and ’fast’ for
F) and that this transition renders z2-M unable to
protect large molecular weight substrates from
proteolysis.4a5 To test the antiproteinase activity of
z,.-M, Barrett et al.4 assayed the proteolytic activity of
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trypsin against a large molecular weight substrate in
the presence of (x2-M SO that the trapping of trypsin
by (x2-M reduced or totally inhibited the enzymatic
activity. But the pre-treatment of (x2-M by ammonium
salts (such as methyl ammonium chloride) impaired
the inhibitory power of (x2-M on trypsin.
The purpose of this study was to demonstrate that
O2-M is highly sensitive to oxidation and that acti-
vated PMNL or some of their products of activation
can destroy its antiproteinase activity, as they do for
0q-PI.6,7 The results are in agreement with those
reported previously by Reddy et al.6 Taken together,
these findings confirm Weiss’ hypothesis of a poss-
ible oxidation of {Xa-M by activated neutrophils with
possible dramatic consequences on tissue destruc-
tion during acute inflammation.
Materials and Methods
Materials: The chemicals reagents (analytical grade)
were purchased as follows: trihydroxyl methyl amino
methane (Tris), sodium and potassium chloride, cal-
cium and magnesium chloride, sodium dihydrogeno-
and potassium monohydrogenophosphate, ammo-
nium sulphate, hydrogen peroxide (H202),
hypochlorous acid (HOCl), dimethylsulphoxide,
glucose, toluene and Brij 35 from Merck Chemical;
methylammonium chloride fromJanssen Chemica; N-
formyl L-methionyl L-leucyl-t-phenylalanine (FMLP),
cytochalasin B, tetrazolium nitroblue, superoxide
dismutase, cetyltrimethylammonium bromide,
thiourea and hide powder azure from Sigma; bovine
trypsin, soybean trypsin inhibitor (SBTI), bovine 2-
macroglobulin and Chromozym TRY (carbobenzoxy-
t-valyl-t-glycyl-t-arginyl p-nitroanilide) from
Boehringer; Dextran T500, Ficoll-Paque; Sephadex
SP50 from Pharmacia Fine Chemical; and Aca 34
from IBF.
The bovine trypsin preparation was standardized
by active site titration17 and was found to contain 83%
active enzyme. The trypsin concentrations in the
assays are expressed as active trypsin. The purity of
trypsin, 0ti-macroglobulin and myeloperoxidase
were controlled by SDS-polyacrylamide gel
electrophoresis (3-15%).
Preparation and activation of polymorphonuclear
leukocytes: Polymorphonuclear leukocytes (PMNL)
were isolated from human blood of healthy donors
following the technique of Borgeat and
Samuelsson. TM After a first centrifugation (25 min at
200 x g), the plasma was discarded and the. ’buffy
coat’ was resuspended in one volume of saline and
a half volume of 6% Dextran T 500 in saline, until
erythrocytes settled down. The ’foamy coat’ was
layered over Ficoll-Paque. The PMNL pellets were
collected after centrifugation (100 x g, 20 min at
20C) and briefly exposed to Tris (2.06%)-ammo-
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nium chloride (0.83%) at pH 7.4, to lyse any remain-
ing erythrocytes. After a last centrifugation (15 min at
20C, 200 g), the cells were adjusted to 20 x 106
cells/ml of phosphate buffered saline (PBS: Na2HPO4,
10
-2 M; KH2PO4, 1.5 x 10-3 M; KC1, 2.7 10-3 M; NaCI,
0.14 M; glucose, 7.5 x 10-3 M, pH 7.3) for further use.
For activation, 2 x 106 cells (in 0.1 ml PBS) were
treated with 10/1 of FMLP (100 /g/ml), 10 /1 of
cytochalasin B (250/g/ml) and 10 lal of a 200 mM
CAC12-50 mM MgC12 solution in PBS. In order to prove
the PMNL activation by FMLP and cytochalasin B, we
used the superoxide dismutase inhibitable reduction
of either tetrazolium nitroblue (NBT) or
ferricytochrome C to measure the rate of superoxide
anion generation by activated cells. 1,19
2 x 106 PMNL in 0.1 ml PBS and 0.9 ml of either a
10-3M NBT or ferricytochrome C solution were incu-
bated for 5 min at 37C. After addition of FMLP and
cytochalasin B, the absorbance at 522 or 550 nm was
followed and compared with the same assay in the
presence of 60 /g of superoxide dismutase, the
specific enzyme destroying the superoxide anion.
Before the test on the activity of trypsin, {Xa-M was
preincubated with PMNL for 20 min at 37C in a final
volume of i ml ((xi-M final concentration, 800/g/ml).
Control assays were made by incubation of 0t,.-M in
the same conditions but with non-activated PMNL.
After centrifugation (600 x g, 5 min at 20C), the
supernatants were pipetted and used for trypsin
activity measurement. Control experiments of the
direct action of activated or non-activated PMNL on
trypsin activity were carried out.
To rule out a possible release of a trypsin-like
enzyme by activated PMNL, which would interfere
with the release of the dye from the substrate, we
looked at a possible trypsin-like activity in the
supernatant of PMNL by using a low molecular
weight chromogenic substrate, Chromozym TRY
(R)
(carbobenzoxy-t-valyl-t-glycyl-t-arginyl-p-
nitroanilide).’ Trypsin cleaves this substrate releas-
ing p-nitroaniline, the absorbance of which is deter-
mined at 405 nm. The working solution of
Chromozym TRY
(R) was prepared by dilution of 2 ml
of a concentrated solution (1.5mg/ml of
dimethylsulphoxide) in 25 ml of Tris-HCl buffer
(0.1 M, pH 8.0) added to CaCl,. (0.02 M). In the assay
tube, 1 ml of the working solution of Chromozym
TRY
(R) is mixed with 0.8 ml of Tris-HCl buffer and
0.2 ml of the supernatant from activated PMNL. After
10 min of reaction, the absorbance was measured
against the same test without supernatant (control
test). A standard curve was established with concen-
trations of bovine trypsin ranging from 2 to 100 ng/
ml.
Effects of various substances on ot2-macroglobulin
activity: MPO was purified from PMNL isolated from
30 of blood from healthy donors, according to thePMNL inactivate {x2-macroglobulin
method described previously.
21 The purity of the final
preparation was checked by the ratio of absorbance
at 430 nm vs. 280 nm and by analytical
electrophoresis either on 9% polyacrylamide gel at
pH 4.6 or on gradient polyacrylamide gel (7-15%) in
the presence of 0.1% sodium dodecyl sulphate and
2-mercapto-ethanol, in 0.1 M Tris-glycine buffer at
pH 8.3.
22
To demonstrate a possible role played by MPO in
2-M inactivation, the following experiments were
carried out. Forty lal of MPO (1.25 10-
M in phos-
phate buffer 0.1 M, NaCl 0.2 M), 10 I1 of H20
(10-4 M) and 50/1 of 2-m (1600 /g/ml in Tris-HCl
buffer) were incubated for 10 min at 37C. 100/1 of
trypsin (14 /g/ml in Tris-HCl buffer) were then
added, the volume of the assay tube was adjusted to
0.5 ml with Tris-HCl buffer and a new incubation
was performed for 10 min at 37C. Next, the
proteolytic activity of trypsin was assayed as de-
scribed above. To test that the trypsin activity was not
directly inhibited by MPO or H202, the same assays
were performed in the absence of 2-m (control
assay).
The enzymatic activity of MPO produces oxidant
chlorinated species, particularly hypochlorous acid
(HOCl) which could play a role in 0t,.-M inactivation.
So, its direct action on {2-M was tested. In each assay,
50 /1 of {2-M (1600 /g/ml) and 50 /1 of HOC1
(10-4M) were incubated for 5 min at 37C. One
hundred lal of trypsin (14/g/ml) were added to the
assay tube and the volume adjusted to 0.5 ml with
Tris-HCl buffer. After 10 min incubation at 37C, the
proteolytic activity of trypsin was tested. Control
assays were made without O2-M.
The effects of thiourea, an inhibitor of MPO activ-
ity, was assessed by incubating PMNL (20 x 106 cells/
ml) for 5 min at 37C with 10/1 of a thiourea solution
(10-4 m). 23 The cells were then activated in the pres-
ence of O2-m (see above). After incubation for 20 min
at 37C, the supernatants were used to test the
remaining inhibiting activity of {2-M on trypsin activ-
ity. Control tests were made in the same manner with
all the reagents except 2-M.
Assay of proteinase inhibitory activity of
macroglobulin: The activity of Ot2-M was determined
as its inhibition on the proteolytic activity of trypsin
against a large molecular weight substrate, hide pow-
der azure. TM Free trypsin breaks the link between the
hide powder and a dye, Remazol Brilliant Blue,
releasing it in the supernatant where its absorbance
is determined at 595 nm (A595). When complexed by
O2-M trypsin is inactive against this substrate.
All the assays were prepared in triplicate and the
reagents were dissolved in the test buffer, 0.1 M Tris-
HC1 at pH 8.1 added to 0.02 M CaC1,. and 0.1% Brij
35. In each of the triplicate assay tubes, 0.1 ml of
trypsin (14/g/ml) was incubated for 10 min at 37C
with 0.1 ml of O2-m (800/g/ml) in a total volume of
0.5 ml made up with the test buffer. Water (0.5 ml)
was then added to the tube, followed by 0.8 ml of the
substrate suspension (12.5 mg of hide powder azure
per ml in 0.6 M sucrose, 0.1% Brij 35, 0.03% toluene).
After an incubation of 20 min at 37C with continu-
ous shaking, 1 ml of water was added and after
centrifugation (2 000xg for 5 min), the A595 of
supernatant was determined.
To verify the existence of a linear relationship
between increasing concentrations of trypsin and the
amount of the dye released from a constant concen-
tration of the substrate, a standard curve of 4 to
20/g of trypsin/ml was determined in the absence of
{2-M. In the same manner, to verify the existence of
a linear relationship between increasing amounts
of O2-m and the inhibition of trypsin activity, a
constant concentration of trypsin was incubated with
increasing amounts of 2-M from 100 to 1 000/g/ml.
Soybean trypsin inhibitor (SBTI) is an efficacious
inhibitor of trypsin that blocks the active centre of the
enzyme. 24 Consequently, when preincubated with
trypsin (5 min at 20C), it has to prevent the enzyme
action on the hide powder azure substrate. SBTI was
used in these experiments to prove the validity of the
test assay of trypsin enzymatic activity.
Methylammonium chloride causes the cleavage of
the thioester bonds which link the four sub-units of
{2-M. This cleavage changes the 2-M conformation,
leading to 2-M inactivation. 4,15 Methylammonium
chloride (in concentrations between 20 and 400 mM)
was preincubated with 2-m (800 lg/ml) for 30 min
at 20C. Trypsin activity was then tested in the pres-
ence of this inactivated 2-M, following the previ-
ously described technique. Control assays were car-
ried out in the absence of O2-M to measure the direct
influence of methylammonium chloride on trypsin
activity.
Results
Using the technique of Barrett,
4 a linear relation-
ship was found between the amount of trypsin incu-
bated in the presence of a fixed concentration of the
substrate (10 mg) and the amount of the released
dye, for trypsin concentrations ranging from 2 to 20
g/ml (A595 from 0.05 to 0.32). For further assays, a
fixed trypsin concentration of 14 lg/ml was chosen
giving a reproducible A595 of 0.22 + 0.02 (n 30). The
A595 obtained for this trypsin concentration in the
absence of O2-m was taken as 100% of trypsin activity
(Fig. 1, Column 1). The enzyme assay was affected by
the trypsin inhibitor SBTI, and the trypsin activity
(14 /g/ml) was completely inhibited for an SBTI
concentration of 15 /g/ml, which represents an
SBTI/trypsin molar ratio of 1.1 (Fig. 1, Column 6). A
linear relationship was observed between increasing
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FIG. 1. Role of %-macroglobulin (%-M) and soybean trypsin inhibitor
(SBTI) on trypsin activity. Column 1, trypsin alone (14 pg/ml); Columns
2, 3, 4 and 5, increased concentrations of %-M (200, 400, 600, 800 pg/
ml); Column 6, soybean trypsin inhibitor (15 pg/ml); Column 7, %-M (800
pg/ml) inactivated by methylammonium chloride (400 mM).
concentrations of O2-M (from 200 to 800/,g/ml) and
the activity of trypsin (fixed concentration of trypsin,
14/g/mD (Fig. 1, Columns 2, 3, 4 and 5). The enzyme
activity was completely abolished for an 02-M
concentration of 800 lag/ml, which represents a
trypsin/0ti-M ratio of 2 on the basis of the trypsin and
02-M molecular weights of 23 and 725 kDa, respec-
tively. This concentration (800 lag/ml O2-M) was cho-
sen for further assay. When preincubated with O2-m
methylammonium chloride blocks the antiproteinase
activity of 0t2-M. A complete inactivation of 02-M (800
lag/ml) was observed for a methylammonium chlo-
ride concentration of 400 mM (Fig. 1, Column 7). At
the same concentration, methylammonium chloride
was totally inactive on trypsin alone.
Fig. 2 shows the increasing production of super-
oxide anion by PMNL activated by FMLP and cyto-
chalasin B. The absorbance of formazan blue
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FIG. 2. Superoxide anion production by activated polymorphonuclear
leukocytes (PMNL) measured by reduction of tetrazolium nitroblue
(Curves and 2, at 592 nm) or ferricytochrome C (Curves 3 and 4, at
550 nm). or I, activated PMNL (activators: FMLP 1.0 pg and
cytochalasin B 2.5 pg). O or [3, non-activated PMNL.
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FIG. 3. Role of PMNL and MPO in %-M inactivation. Column 1, trypsin
alone (14 pg/ml); Column 2, trypsin + supernatant of activated PMNL;
Column 3, trypsin + supernatant of non-activated PMNL; Column 4,
trypsin +%-M (800 pg/ml); Column 5, trypsin +-M treated by
supernatant of activated PMNL; Column 6, trypsin + %-M treated
by supernatant of non-activated PMNL; Column 7, trypsin + %-M treated
by activated PMNL preincubated with thiourea (10-M); Column 8,
trypsin + MPO (10-7M); Column 9, trypsin+ HOCI (10-7M); Column 10,
trypsin + %-M treated by MPO; Column 11, trypsin + %-M treated by
HOCI (10-z M).
the superoxide anion generated by PMNL) increased
with time for activated PMNL, remaining very low for
non-activated cells. Fig. 2 also shows the progressive
reduction of ferricytochrome C by anion superoxide
produced by activated PMNL after a short period of
latency. The production of superoxide anion by non-
activated cells is given as comparison. For some
PMNL preparations, superoxide anion was produced
(at low levels) without further addition of FMLP and
cytochalasin B, indicating a possible unexpected
activation of the cells during their isolation from
blood. PMNL preparations with this unexpected ac-
tivation were not used for our experiments of 0t2-M
inactivation.
Using the chromozym TRY
(R) technique, proteolytic
activity sufficient for interfering with the assay con-
ditions could not be detected. Additionally, by them-
selves, supernatants of activated or non-activated
PMNL were unable to release the dye from the
substrate. Moreover they did not decrease the release
of the dye from the substrate, which indicates that no
trypsin inhibitor was produced (Fig. 3, Columns 2
and 3). Activated PMNL destroyed the antiproteinase
activity of 0ta-M (Fig. 3, Column 5) since trypsin
activity was completely recovered after treatment of
O2-M by activated PMNL. This O2-M inactivation was
dependent on the activation of PMNL, for non-acti-
vated PMNL did not affect the inhibitory power of 02-
M on trypsin (Fig. 3, Column 6). When thiourea was
added (at the concentration of 10-4 M) to the incu-
bation medium of O2-M with activated PMNL, it
prevented the inactivation of 02-M, resulting in a
complete recovery of 02-M inhibition on trypsin ac-
tivity (Fig. 3, Column 7).
The treatment of O2-M by MPO in the presence of
H202 and C1- inactivated 0t2-M since all the activity of
trypsin was recovered (Fig. 3, Column 10), while the
enzyme was not directly affected by the activity of
MPO (Fig. 3, Column 8). Hypochlorous acid, HOCl,PMNL inactivate (2-macroglobulin
Table 1. Role of H202 and HOCI on trypsin activity















the direct product of MPO activity, was tested alone.
At a concentration of 10-7M, it destroyed the activity
of o,.-M (Fig. 3, Column 11). However, as HOCI is
very oxidant, it was tested directly on trypsin activity.
At concentrations of 10 -5 and 10-4M, it destroyed the
enzyme (Table 1). But in our assay conditions HOC1
(10-7M), had little effect on trypsin activity (Fig. 3,
Column 9). Hydrogen peroxide, at concentrations
between 10-7 and 10 -4 M, did not inactivate trypsin
(Table 1).
When O2-M is inactivated, its antigenic activity
shows little change. Using the immunoprecipitin
analysis technique (immunoelectropherogram), a dif-
ference in mobility of the inactive human ot2-M,
compared with its native active form (Fig. 4), was
observed. A similar effect was observed by Hubbard
et al. for complexed (,,.-M5 and by Barrett eta/. TM
who, using immunoprecipitin analysis, also found a
slight difference. The heights of rockets for the F-02-
M (fast form or complexed by proteinases) were
lower (12 to 29%) than those for the S-O2-M
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FIG. 4. Immunoprecipitin analysis (immunoelectropherogram) of human
%-M (anode at right). Troughs, rabbit antiserum obtained against human
%-M. Panel A, upper well, normal human plasma; lower well, pure native
%-M. Panel B, upper well, %-M treated by activated PMNL; lower well,
%-M treated by human myeloperoxidase. Note the difference in mobility
between the slow native %-M and the fast inactive form after PMNL or
myeloperoxidase treatment.
Discussion
(x2-Macroglobulin (about 1.1 x 10 M) was inacti-
vated by 2 x 10 PMNL. This inactivation was com-
plete, with a total loss of antiproteinase activity, but
needed an activation of the cells, since 2-M treated
by non-activated PMNL conserved its antiproteinase
activity. The control assays allowed us to exclude the
capture of O2-M by the cells or the release of an
inhibitor directly acting on trypsin. The activation of
PMNL can release proteinases (such as elastase)
which, by binding to O2-M could have rendered it
inactive towards trypsin. But it seems difficult to
admit that 2 x 10 cells would have released sufficient
amounts of proteinases to completely complex the
amount of 2-M used in these assays.
When PMNL are activated, they undergo the ’res-
piratory burst’, triggering the activity of membrane
NADPH oxidase leading to the production of excited
forms of oxygen, particularly O2 (superoxide anion)
from which H20 can be generated. 1,26 PMNL activa-
tion also leads to degranulation with the release of
proteolytic and hydrolytic enzymes from granules.
MPO is an important enzyme present in the
azurophilic granules. It uses H202 and halide anions
(CI-, I- etc.) for its enzymatic activity, which generates
various strong oxidants, such as HOC1 and
chloramines. 27,28 The inactivation of O2-M by excited
PMNL can be due to the excited forms of oxygen or
the action of the granulocytic enzymes. It is unlikely
that O2 is responsible for 0t,.-M inactivation. To attack
(x-M, O2 needs to reach this molecule, but, in our
assay conditions, its access to O2-M is limited by its
instability in aqueous media. Moreover, the effects of
O on O2-M were tested using the production of O2
by an acetaldehyde-xanthine oxidase system29 in
buffer with added O2-M. In these conditions, the
antiproteinase activity of O2-M remained unaffected.
Consistent with the conclusion that O2 was not the
primary species involved are the results of a previous
study by Reddy et al. 16 where neutrophil cytoplasts,
able to generate O, and H202 but not HOC1, failed to
inactivate 0t,.-M in the absence of exogenous MPO.
By dismutation, O2 produces H202 which could di-
rectly act on (2-M. However, the use of H202 concen-
trations between 10 -7 and 10 -5M failed to inactivate
o2-M.
Since neither O,. nor H202 appears responsible for
the destruction of O2-M antiproteinase activity, atten-
tion was therefore focused on the role of MPO. The
activation of PMNL leads to their degranulation, with
activation of many enzymes. In presence of H202
produced from O2 dismutation, MPO generates po-
tent oxidant compounds, particularly HOCl. It has
been shown that the activity of MPO inactivates
PI.6,7 This study demonstrates that OL2-M is inactivated
in a similar manner by MPO and that the main
product ofMPO activity, HOCl, is responsible for this
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inactivation. The results are in agreement with those
obtained by Reddy et a1.16 These authors showed that
human O2-M incubated in the presence of activated
PMNL rapidly lost the ability to inhibit neutrophil and
pancreatic elastase activity. They also showed that
PMNL inactivate 2-M by a HOC1 dependent process.
However, it appears from our observations that this
inactivation of O2-M by HOC1 is nonspecific, since
trypsin itself can be totally destroyed by HOCl, but
only at higher concentrations (10-5M) of this mol-
ecule. In the same manner, H202 also has a destroy-
ing effect on 0t,.-M, but hydrogen peroxide at concen-
trations of 10-2M is needed for this destruction. It is
probable that inactivation of 2-M occurs by the
destruction of the S-S bonds between the four
subunits of the protein, leading to their dissociation.
The limited reduction of O2-M produces monomers
(180 kDa) which reassociate after proteinase treat-
ment but do not prevent proteinases from cleaving
hide powder azure. TM Larsson et al.3 found that
enzymatic treatment of 2-M cleaves the disulphide
bonds inhibiting the further binding of trypsin.
Moncino et al.,1 by chemical reduction of 2-M with
dithiotreitrol, obtained O2-m monomers retaining
their proteinase binding capacity, but becoming un-
able to inhibit the enzymatic activity of the bound
proteinases. By electrophoresis, we confirmed that,
after treatment by activated PMNL or MPO, the
electrophoretic pattern of 2-M was modified with
the disappearance of the 720 000 kDa band and the
presence of new bands localized around 180 000
kDa. These assays were carried out using bovine
2-M, as well as 2-m purified from human plasma.
This human 2-M, when treated by activated PMNL or
MPO, loses its trypsin inhibitory capacity in the same
manner as bovine {2-M.
In our experimental conditions, 2-M (10-9M) was
completely inactivated by a 20 min incubation in the
presence of excited PMNL, but 2 106 cells per assay
were used. Moreover, these cells remained in close
contact with {2-M for a long time. While PMNL can
exert strong destructive effects on host tissues,5,2,
our experimental conditions are far from being com-
parable to a normal in vivo situation, where plasma
protectors will counteract any PMNL destroying activ-
ity on 02-m. Therefore, the extent to which in vivo
2-m inactivation by triggered PMNL could occur and
contribute to tissue destruction through imbalance
between proteases and antiproteases is still obscure
and requires further studies. It is worth remembering,
however, that we have measured important plasma
concentrations of MPO in inflammation states asso-
ciated with ARDS, sepsis or acute pancreatitis.4 On
the other hand, decreased plasma and serum concen-
trations of ,.-M have been reported in ARDS and
septic patients. Furthermore, these decreased plasma
or serum concentrations of O2-M are measured by
routine immunological or immunoelectrophoresis
techniques that are unable to easily differentiate the
active from the inactive form of O2-M so that the
plasma or serum concentrations of the protein meas-
ured by these techniques do not.reflect the capacity
of 2-M to inhibit proteases. Taken together, these
findings indicate that in vivo inactivation of 2-M
cannot be ruled out, but as suggested above the
occurrence of this phenomenon and its possible
involvement in tissue destruction by active protease
in inflammatory diseases remain to be firmly demon-
strated.
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